[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@JoseRestonVA Jose Hurtado
Jose Hurtado posts on X about $orka, $apge, $syre, $rna the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +130%
- X Year XXXXXXX +258%
Mentions: X #
- X Week XX -XXXX%
- X Month XXX -XX%
- X Months XXX +86%
- X Year XXX +152%
Followers: XXXXX #
- X Week XXXXX +0.60%
- X Month XXXXX +4.10%
- X Months XXXXX +63%
- X Year XXXXX +116%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence stocks XXXXX% finance XXXX%
Social topic influence $orka 5.77%, $apge 3.85%, $syre #1, $rna 3.85%, $janx 3.85%, $zeal #1, $smg 1.92%, ipo 1.92%, $ptgx 1.92%, $exas XXXX%
Top accounts mentioned or mentioned by @jfais20 @biotech2k1 @ltbioinvestor @monacobiotech @caesarcapitalz @dmitrykovalchuk @bigmurf58 @juansar14616081 @semodough @aggregategains @a_a_free @oncinvestor @andreagtc @biotechobserver @pharmafather123 @biohazard3737 @unemon1 @persimmonti @samputnam @grindeoptions
Top assets mentioned Oruka Therapeutics, Inc. Common Stock (ORKA) Apogee Therapeutics, Inc. Common Stock (APGE) Avidity Biosciences, Inc. Common Stock (RNA) Janux Therapeutics, Inc. Common Stock (JANX) The Scotts Miracle-Gro Company (SMG) Protagonist Therapeutics, Inc (PTGX) Exact Sciences Corp (EXAS) Insmed, Inc. (INSM) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) BridgeBio Pharma, Inc. Common Stock (BBIO) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Revolution Medicines, Inc. Common Stock (RVMD) Natera, Inc. Common Stock (NTRA) Regeneron Pharmaceuticals Inc (REGN) Biogen Inc (BIIB) Dyne Therapeutics, Inc. Common Stock (DYN) Sarepta Therapeutics, Inc. (SRPT) Itau Unibanco Holding S.A. (ITUB) NuCypher (NU) Kymera Therapeutics, Inc. Common Stock (KYMR) Novartis AG (NVS)
Top Social Posts
Top posts by engagements in the last XX hours
"In my Swiss portfolio started a small position in Swiss Marketplace Group $SMG. I plan to accumulate from time to time with a LT horizon (buying at a XX% discount from IPO good enough for me)"
X Link 2025-12-08T13:11Z 3368 followers, 2118 engagements
"@bigmurf58 Good luck. I am long and will keep adding to $ORKA on weakness"
X Link 2025-11-21T20:39Z 3365 followers, 1331 engagements
"I own $APGE $ORKA and $PTGX. I do not own $SYRE but I might do it in XX. I will try to elaborate a little: - APGE is my 3rd bio by size and I own it for more than a year. My hypothesis here is simple: components with derisked MOA with potentially much longer doses than Dupi or lebri combinable somewhat deriskedwhich makes them potentially BIC in large TAM. Leadership team is solid (Jefferies webcast is highly recommended) and catalysts 2026. In a sense it has some parallels to $MTSR but in different indications (this was also brought up by the JEF analyst). If the hypothesis plays out current"
X Link 2025-11-22T06:41Z 3365 followers, XXX engagements
"Wrong take. A simple look at the main components of the ETF tells the real story behind it. Just as example looking at the top XX names shown in StareStreet site: - $EXAS and $RNA (bought out) - $INSM $MDGL $BBIO $IONS - commercial stage bios with potential blockbuster products - $RVMD $NTRA - high quality bios - $REGN (see Dupixent revenues) $BIIB (large commercial) The list goes on. Yes at the end of the list you can find lower-quality bios that could potentially benefit from the ETF but the sector has produced true outperformersand investors have benefited by looking under the ETF"
X Link 2025-11-28T21:09Z 3365 followers, XXX engagements
"@monaco_biotech Sold $JANX at loss. This leadership team inspires no confidence. Not willing to wait"
X Link 2025-12-01T22:36Z 3365 followers, 3183 engagements
"Rebought $JANX at $XXXXX for a trade"
X Link 2025-12-02T14:36Z 3365 followers, 4167 engagements
"Zrich this evening. That building with the red lightsthat was Credit Suisse"
X Link 2025-12-05T19:27Z 3365 followers, 2704 engagements
"@bioinvestor24 Different exons. $RNA has Exon-44. $DYN trial seems it is targeting Exon-51. That goes to $SRPT to care about it not Vas"
X Link 2025-12-07T21:46Z 3365 followers, XXX engagements
"Galderma $GALD in the Swiss market - not only about Nemluvio launch. Stellar performance since April 25"
X Link 2025-12-08T09:26Z 3365 followers, 2665 engagements
"@Biotech2k1 Itau is a great bank. Compared to $NU $ITUB it is orders of magnitude cheaper"
X Link 2025-12-08T15:45Z 3366 followers, XXX engagements
"@_le_Lounge Still early. No catalysts nearby. That said the current valuation today considering that they have a Phase-3 ready asset.and a Phase-2 of the same asset in another indication to start. I will continue adding to $LBRX from time to time. No rush"
X Link 2025-12-08T21:59Z 3366 followers, XXX engagements
"@a_a_free Now I need to look at $SYRE To think that $ORKA was here just a few months ago"
X Link 2025-12-10T20:26Z 3365 followers, XXX engagements
"@LTbioinvestor @jfais20 Thank you You know how this iswith its ups and downs. Just trying to finish the year the way I would like to finish"
X Link 2025-12-11T14:26Z 3366 followers, XXX engagements
"Opened a small position of Zealand Pharma in the Danish market - $ZEAL"
X Link 2025-10-07T10:41Z 3368 followers, 4067 engagements
"@A_May_MD @Steptradez $APGE might not be a me-too. I fundamentally disagree here"
X Link 2025-12-08T22:12Z 3368 followers, 1524 engagements
"@semodough @jfais20 I dont touch $KYMR"
X Link 2025-12-12T15:00Z 3368 followers, XXX engagements
"@monaco_biotech $ZEAL is more H1 XX with Petrelintide in Phase X obesity and Survodutide Phase X MASH (this one could be very interesting as well)"
X Link 2025-12-13T08:23Z 3368 followers, XXX engagements
"@aggregategains @PCM_bio No there wasnt. It was just Novartis in the end. Thanks but I am wrong many many many times"
X Link 2025-12-13T22:19Z 3368 followers, XXX engagements